Serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) has been shown to improve sleep measures among children with attention-deficit/hyperactivity disorder (ADHD), according to study results presented at Psych Congress 2022 held from September 17 to 20, 2022, in New Orleans, Louisiana.

Two studies have revealed that certain disorders of the CAPRIN1 gene have significant consequences for people. First, the research team showed that insufficient production of the protein CAPRIN1 in the brain can lead to developmental differences, including autism spectrum disorders, attention deficit hyperactivity disorder (ADHD), and language disorders. Furthermore, the scientists identified a specific mutation…

While city officials were able to calculate the physical destruction caused by Hurricane Sandy years ago, experts are still grasping the scope of the mental anguish it caused city residents — even those who were in the womb when it happened nearly a decade ago. In a study published Wednesday in the Journal of Child…

“I’m constantly nervous that I won’t be able to get my medicine, and I’ll get fired and not be able to find another job and turn back into a gross depressed garbage monster who hates himself for not being able to do his laundry.”

Two more pharmaceutical companies are having difficulty supplying Adderall to US patients with attention-deficit/hyperactivity disorder as shortages plague the market. Lannett Co. and Par Pharmaceuticals, part of Endo International Plc, are the latest companies with limited supply of some doses of generic extended-release Adderall, according to a website updated Monday by the University of Utah’s…

According to the World Health Organization, adults with untreated ADHD lose on average 22 days of productivity per year. Employees with ADHD are 30% more likely to have chronic employment issues, 60% more likely to be fired from a job, and three times more likely to quit a job impulsively than their non-ADHD counterparts. Why…

Laurie Kulikosky, CAE, Will Join the Leading Nonprofit Organization Serving the ADHD Community LANHAM, Md., Sept. 20, 2022 /PRNewswire/ — CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder)―the leading resource for children and adults with ADHD, their families, educators, and healthcare professionals―is proud to announce the appointment of Laurie Kulikosky, CAE, as the organization’s new Chief…

Around the Practice: Management of Adult with Attention Deficit/Hyperactivity Disorder (ADHD) – Episode 3. Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to diagnose adults with ADHD based on patient presentation.

Around the Practice: Management of Adult with Attention Deficit/Hyperactivity Disorder (ADHD) – Episode 2. Experts in ADHD compare the diagnosis and management of ADHD in adults and children.

Around the Practice: Management of Adult with Attention Deficit/Hyperactivity Disorder (ADHD) – Episode 1. Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss the prevalence of adult ADHD.

Key Takeaways: Attention-deficit/hyperactivity disorder (ADHD) was shown to be a risk factor for cardiovascular disease.

A study published in the Journal of the American Academy of Child & Adolescent Psychiatry found treatment-specific and shared predictors for response to pharmacotherapies for attention-deficit/hyperactivity disorder (ADHD) among children.